BIA launches videos and explainer documents celebrating UK bioscience and revealing the cutting-edge R&D taking place in biotech companies around the UK

The UK BioIndustry Association (BIA) has today launched a series of four explainer booklets and five videos that celebrate the fantastic work taking place in UK bioscience companies to create innovative new drugs and treatments for patients.

The videos and explainers cover key areas of biotechnology including genomics, cell and gene therapy, antimicrobial resistance and engineering biology, as well as a video with the BIA charity of the year Parkinson’s UK looking at how artificial intelligence can help boost R&D into Parkinson’s.

All of the materials will be made available at the UK Bioscience Forum on Thursday 18 October, which brings together stakeholders from across the UK bioscience ecosystem for a day of panel discussions, networking and presentations. The keynote speaker for the event is Sir Mark Walport who will be updating attendees on how UK Research and Innovation (UKRI) will support the life sciences sector in the future.

BIA CEO, Steve Bates, said: “UK bioscience companies are at the forefront of these innovative, converging disciplines and these materials give a snapshot of the cutting-edge R&D that BIA member companies are engaged in to bring new treatments to patients.”

“The science profiled in these explainers has the potential to change the lives of patients living with diseases across the globe. The vibrancy of the UK bioscience ecosystem continues to attract top talent and investment from around the world and demonstrates the ability of our sector to weather political storms.”

Case studies and expert opinion for the explainers and videos came from the BIA’s Advisory Committees and working groups. The BIA’s Advisory Committees are crucial mechanisms for highlighting the most relevant issues facing bioscience companies. Committee members include influential experts from across the sector.

You can view all of the new materials on the strategic technologies section of the BIA website.

Notes to editors

Explainer reports: Antimicrobial Resistance, Genomics, Cell and Gene Therapy, Engineering Biology

Videos: Parkinson’s UK & Benevolent AI, Antimicrobial Resistance, Cell and Gene Therapy, Engineering Biology, Genomics 

Contact: Ed Sexton, Senior Communications Manager, BIA 

[email protected] 02076302196

About the BIA                    

Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.   

For further information, please go to www.bioindustry.org and twitter.com/BIA_UK

More within